EUVIMEDEUVIMED entdecken
Crossref

Novel Angiogenic Factors for Predicting Preeclampsia: sFlt-1, PlGF, and Soluble Endoglin~!2008-08-29~!2008-12-15~!2009-01-02~!

Yu Chen

The Open Clinical Chemistry Journal · 2009

DOI: 10.2174/1874241600902010001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Open Clinical Chemistry Journal, 2009. Verfasst von Yu Chen. Die Arbeit wurde bisher 16-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Preeclampsia is a devastating multisystem syndrome and is a major cause of maternal, fetal and neonatal morbidity and mortality.Angiogenic factors contribute to the molecular mechanisms of preeclampsia and its main phenotypes such as hypertension and proteinuria.Very recently, novel anti-angiogenic proteins including soluble fms-like tyrosine kinase-1 (sFlt-1) and soluble endoglin (sEng), and one pro-angiogenic protein placental growth factor (PlGF) have been found to be significantly abnormal several weeks preceding the onset of clinical signs and symptoms.Automatic immunoassays are being developed for sFlt-1 and PlGF.This article will summarize our current knowledge of these markers and their roles on predicting preeclampsia.

Zitieren

APA

Chen, Y. (2009). Novel Angiogenic Factors for Predicting Preeclampsia: sFlt-1, PlGF, and Soluble Endoglin~!2008-08-29~!2008-12-15~!2009-01-02~!. The Open Clinical Chemistry Journal. https://doi.org/10.2174/1874241600902010001

Vancouver

Chen Y. Novel Angiogenic Factors for Predicting Preeclampsia: sFlt-1, PlGF, and Soluble Endoglin~!2008-08-29~!2008-12-15~!2009-01-02~!. The Open Clinical Chemistry Journal. 2009. doi:10.2174/1874241600902010001

BibTeX
@article{Chen2009,
  author = {Chen, Yu},
  title = {Novel Angiogenic Factors for Predicting Preeclampsia: sFlt-1, PlGF, and Soluble Endoglin~!2008-08-29~!2008-12-15~!2009-01-02~!},
  journal = {The Open Clinical Chemistry Journal},
  year = {2009},
  doi = {10.2174/1874241600902010001}
}
Kostenlos starten →